Jan 27 (Reuters) - Theraclion SA ALTHER.PA :
* 2019 : THERACLION DEMONSTRATES ITS LEADERSHIP IN THYROID
AND
VEINS NONE INVASIVE TREATMENTS
* ACHIEVED A TURNOVER OF EUR 2,784 THOUSAND IN 2019
* IN 2020, THERACLION EXPECTS TO REACH BETWEEN 30% AND 50%
SALES
GROWTH.
* AT DECEMBER 31, 2019, THERACLION'S AVAILABLE CASH POSITION
AMOUNTED TO EUR 1.4 MILLION
* THERACLION ESTIMATES THAT IT WILL BE ABLE TO COVER ITS
CASH
REQUIREMENTS UNTIL END OF 2020.
Source text for Eikon: ID:nBw92QRbga
Further company coverage: ALTHER.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))